Clinical Trials List
2024-12-02 - 2027-12-31
Phase I/II
Recruiting4
ICD-10C90.00
Multiple myeloma not having achieved remission
ICD-10C90.02
Multiple myeloma in relapse
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9203.00
Multiple myeloma, without mention of remission
xxxxxx
-
Trial Applicant
Linical
-
Sponsor
xxxxxx
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chien-Chin Lin Division of Others -
- CHENG-HONG TSAI Division of General Internal Medicine
- 田豐銘 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Yu Lien Division of Hematology & Oncology
- 鄭富銘 Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- 王幸婷 Division of Hematology & Oncology
- 陳珈妤 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kuan-Der Lee 無
- CHENG-HSIEN LIN 無
- 鄧齡喬 無
- PO-HSIEN LI 無
- 曾貫宇 無
- Cheng-Lun Lai 無
- 吳承翰
- HSIN-CHEN LIN 無
- PO-WEI LIAO 無
- YU-HSUAN SHIH
- ZHENG-WEI ZHOU 無
- 楊陽生 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
21 participants
-
Global
21 participants
